FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110705886> ?p ?o ?g. }

• W2110705886 endingPage "1276" @default.
• W2110705886 startingPage "1268" @default.
• W2110705886 abstract "Abstract —The vitronectin receptor (α v β 3 ) mediates several biological processes that are critical to the formation of a neointima after coronary interventions. Blockade of α v β 3 could reduce neointima formation by inhibiting smooth muscle cell migration, decreasing transforming growth factor-β 1 expression, enhancing apoptosis, or reducing neovasculature. The effects of short-term administration of Vitaxin, a humanized monoclonal antibody to α v β 3 , on the responses to balloon injury were tested in hyperlipidemic rabbits. Balloon angioplasty was performed on the iliac arteries of male New Zealand White rabbits that were fed an atherogenic diet for 1 week before injury and until euthanization at 4 weeks. Rabbits were given either saline (control) or 1 of 2 dosing regimens of Vitaxin (high dose, 5.0 mg/kg, and low dose, 0.5 mg/kg), which were administered intra-arterially before injury and intramuscularly on days 2 and 3. High-dose and low-dose Vitaxin were equally effective in decreasing neointima formation even in the presence of hypercholesterolemia, a stimulus to α v β 3 expression. Vitaxin reduced transforming growth factor-β 1 and enhanced apoptosis in injured arteries. Despite these positive effects, Vitaxin administration was associated with a reduction in artery size, indicating a negative effect on remodeling. Vitaxin has a potential role in preventing intimal hyperplasia, especially if the negative effects on remodeling can be overcome, by dose adjustment or other strategies." @default.
• W2110705886 created "2016-06-24" @default.
• W2110705886 creator A5015612883 @default.
• W2110705886 creator A5041348555 @default.
• W2110705886 creator A5041872400 @default.
• W2110705886 creator A5085840629 @default.
• W2110705886 date "1999-06-11" @default.
• W2110705886 modified "2023-09-25" @default.
• W2110705886 title "Vitaxin, a Humanized Monoclonal Antibody to the Vitronectin Receptor (α _v β ₃ ), Reduces Neointimal Hyperplasia and Total Vessel Area After Balloon Injury in Hypercholesterolemic Rabbits" @default.
• W2110705886 cites W1577857859 @default.
• W2110705886 cites W1886264513 @default.
• W2110705886 cites W1946263363 @default.
• W2110705886 cites W1968051889 @default.
• W2110705886 cites W1969891188 @default.
• W2110705886 cites W1971549100 @default.
• W2110705886 cites W1985093096 @default.
• W2110705886 cites W1988090831 @default.
• W2110705886 cites W1990105301 @default.
• W2110705886 cites W1993255160 @default.
• W2110705886 cites W2000352826 @default.
• W2110705886 cites W2002867354 @default.
• W2110705886 cites W2006487883 @default.
• W2110705886 cites W2008113515 @default.
• W2110705886 cites W2009355282 @default.
• W2110705886 cites W2013417615 @default.
• W2110705886 cites W2021934088 @default.
• W2110705886 cites W2022852324 @default.
• W2110705886 cites W2029231027 @default.
• W2110705886 cites W2029773366 @default.
• W2110705886 cites W2034842897 @default.
• W2110705886 cites W2048093095 @default.
• W2110705886 cites W2053001031 @default.
• W2110705886 cites W2054411344 @default.
• W2110705886 cites W2072103796 @default.
• W2110705886 cites W2095498651 @default.
• W2110705886 cites W2114115245 @default.
• W2110705886 cites W2120927716 @default.
• W2110705886 cites W2129963242 @default.
• W2110705886 cites W2131243830 @default.
• W2110705886 cites W2137570167 @default.
• W2110705886 cites W2141117188 @default.
• W2110705886 cites W2157166784 @default.
• W2110705886 cites W2317358310 @default.
• W2110705886 cites W4232671899 @default.
• W2110705886 doi "https://doi.org/10.1161/01.res.84.11.1268" @default.
• W2110705886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10364564" @default.
• W2110705886 hasPublicationYear "1999" @default.
• W2110705886 type Work @default.
• W2110705886 sameAs 2110705886 @default.
• W2110705886 citedByCount "59" @default.
• W2110705886 countsByYear W21107058862012 @default.
• W2110705886 countsByYear W21107058862013 @default.
• W2110705886 countsByYear W21107058862014 @default.
• W2110705886 countsByYear W21107058862017 @default.
• W2110705886 countsByYear W21107058862018 @default.
• W2110705886 countsByYear W21107058862019 @default.
• W2110705886 countsByYear W21107058862020 @default.
• W2110705886 countsByYear W21107058862021 @default.
• W2110705886 crossrefType "journal-article" @default.
• W2110705886 hasAuthorship W2110705886A5015612883 @default.
• W2110705886 hasAuthorship W2110705886A5041348555 @default.
• W2110705886 hasAuthorship W2110705886A5041872400 @default.
• W2110705886 hasAuthorship W2110705886A5085840629 @default.
• W2110705886 hasBestOaLocation W21107058861 @default.
• W2110705886 hasConcept C126322002 @default.
• W2110705886 hasConcept C126894567 @default.
• W2110705886 hasConcept C134018914 @default.
• W2110705886 hasConcept C142724271 @default.
• W2110705886 hasConcept C185592680 @default.
• W2110705886 hasConcept C190283241 @default.
• W2110705886 hasConcept C2777339539 @default.
• W2110705886 hasConcept C2777562237 @default.
• W2110705886 hasConcept C2778095995 @default.
• W2110705886 hasConcept C2778283817 @default.
• W2110705886 hasConcept C2778583881 @default.
• W2110705886 hasConcept C2779751240 @default.
• W2110705886 hasConcept C2780326628 @default.
• W2110705886 hasConcept C2992686903 @default.
• W2110705886 hasConcept C55493867 @default.
• W2110705886 hasConcept C71924100 @default.
• W2110705886 hasConcept C98274493 @default.
• W2110705886 hasConceptScore W2110705886C126322002 @default.
• W2110705886 hasConceptScore W2110705886C126894567 @default.
• W2110705886 hasConceptScore W2110705886C134018914 @default.
• W2110705886 hasConceptScore W2110705886C142724271 @default.
• W2110705886 hasConceptScore W2110705886C185592680 @default.
• W2110705886 hasConceptScore W2110705886C190283241 @default.
• W2110705886 hasConceptScore W2110705886C2777339539 @default.
• W2110705886 hasConceptScore W2110705886C2777562237 @default.
• W2110705886 hasConceptScore W2110705886C2778095995 @default.
• W2110705886 hasConceptScore W2110705886C2778283817 @default.
• W2110705886 hasConceptScore W2110705886C2778583881 @default.
• W2110705886 hasConceptScore W2110705886C2779751240 @default.
• W2110705886 hasConceptScore W2110705886C2780326628 @default.
• W2110705886 hasConceptScore W2110705886C2992686903 @default.
• W2110705886 hasConceptScore W2110705886C55493867 @default.
• W2110705886 hasConceptScore W2110705886C71924100 @default.
• W2110705886 hasConceptScore W2110705886C98274493 @default.

• next